NContact scores 510(k) clearance for next-gen cardiac system

01/24/2013 | MassDevice.com (Boston)

The FDA has cleared nContact to market EPi-Sense, a next-generation version of the company's VisiTrax heart ablation system. The newly cleared technology comes with advanced sensors, which transmit electrical signals to help electrophysiologists position the device better when performing cardiac ablation surgery.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC